Arnold Ganser

Professor emeritus

Hannover Medical School

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Arnold Ganser is a Professor Emeritus at Hannover Medical School in Germany. His research primarily focuses on acute myeloid leukemia (AML), exploring treatment strategies for refractory cases and the role of allotransplantation in older patients. He has contributed to various publications, including studies on minimal residual disease biomarkers, treatment combinations involving decitabine, and transplantation outcomes in AML. Professor Ganser's work has advanced the understanding of malignant hematology and its clinical applications.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

Peter Hokland

Aarhus University

DENMARK

View details

Masamitsu Yanada

Nagoya University Hospital

JAPAN

View details

Aristoteles Giagounidis

Head of department

Katholisches Klinikum Koblenz

GERMANY

View details

Gerard Socie

FRANCE

View details

Sylvie Freeman

University of Birmingham

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Arnold Ganser

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

The British Journal of Haematology celebrates its 70th birthday. Part one: Malignant haematology 2018–2024

The Menin story in acute myeloid leukaemia—The road to success

How I treat refractory and relapsed acute myeloid leukemia

MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AML

Activity of decitabine combined with all-trans retinoic acid in oligoblastic AML: Results from a randomized 2x2 phase II trial (DECIDER).

Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT.

Role of allotransplantation in older patients with AML.

AML in the elderly—A global view

Correction: Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT.

Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy.

Stereotactic biopsy of a brain lesion caused by <i>hormographiella aspergillata</i>.

Altered Immunomodulatory Responses in the CX3CL1/CX3CR1 Axis Mediated by hMSCs in an Early In Vitro SOD1<sup>G93A</sup> Model of ALS.

Anti-EGFR-Based Therapy in Recurrent or Metastatic HNSCC - What Difference Does it Make?

Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia.

Collaborators (5)

Peter Hokland

Masamitsu Yanada

Aristoteles Giagounidis

Gerard Socie

Sylvie Freeman

Make your next move.